• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[包括产志贺毒素大肠杆菌O-157在内的感染性肠炎假定病原体的药敏模式]

[The drug susceptibility pattern of the presumed etiologic agents of infectious enteritis including verotoxin-producing Escherichia coli O-157].

作者信息

Deguchi K, Suzuki Y, Ishihara R, Ishii Y, Nakazawa A

机构信息

Section of Studies, Tokyo Clinical Research Center.

出版信息

Jpn J Antibiot. 1997 Oct;50(10):829-43.

PMID:9412873
Abstract

The drug susceptibility patterns were investigated for verotoxin-producing Escherichia coli (VTEC) including O-157, Salmonella spp., Vibrio parahaemolyticus and Campylobacter jejuni subsp. jejuni that were obtained in and after July 1996. The results are summarized as follows; 1. We found highly resistant strains of VTEC to tetracycline (TC) and ampicillin (ABPC). Minimum inhibitory concentrations (MIC) of some of the drugs against VTEC in an aerobic condition were significantly different from those in an anaerobic condition. For example, aerobic.anaerobic MIC ranges of the drugs tested were as follows: chroramphenicol (CP): 1.56-3.13 micrograms/ml.0.78-1.56 micrograms/ml, TC: 1.56-> 100 micrograms/ml.0.78-> 100 micrograms/ml, minocycline (MINO): 1.56-12.5 micrograms/ml.0.78-3.13 micrograms/ml, kanamycin (KM): 3.13-6.25 micrograms/ml.25-100 micrograms/ml, fosfomycin (FOM): 3.13-25 micrograms/ml.0.78-6.25 micrograms/ml, norfloxacin (NFLX): < or = 0.025-0.2 microgram/ml.< or = 0.025-0.2 microgram/ml, ABPC: 1.56-> 100 micrograms/ml.0.78-> 100 micrograms/ml and cefaclor (CCL): 1.56-25 micrograms/ml.56-12.5 micrograms/ml. MICs of CP and tetracyclines (TCs) in an anaerobic condition were lower by twofold and the MIC of FOM was lower by fourfold, but the variabilities of MIC-ranges of NFLX, ABPC and CCL were small. The MIC of KM was high. 2. We observed that some of Salmonella spp. were highly resistant to CP, TCs and MINO, and some were moderately resistant to NFLX. 3. The detection frequency of TC-resistant strains and NFLX-insensitive or resistant strains were high among C. jejuni subsp. jejuni. 4. Strains of V. parahaemolyticus and C. jejuni subsp. jejuni were mostly resistant to ABPC and CCL, MICs of which were in high ranges. 5. Fecal concentrations in MINO, KM, FOM and NFLX reported in literatures are high enough to have some antimicrobial activities, leed dose of ABPC and CCL are quite low.

摘要

对1996年7月及以后分离得到的产志贺毒素大肠杆菌(VTEC,包括O-157)、沙门氏菌属、副溶血性弧菌和空肠弯曲菌空肠亚种进行了药敏模式研究。结果总结如下:1. 我们发现VTEC对四环素(TC)和氨苄青霉素(ABPC)有高度耐药菌株。某些药物在需氧条件下对VTEC的最低抑菌浓度(MIC)与厌氧条件下有显著差异。例如,所测药物的需氧-厌氧MIC范围如下:氯霉素(CP):1.56 - 3.13微克/毫升、0.78 - 1.56微克/毫升,TC:1.56 -> 100微克/毫升、0.78 -> 100微克/毫升,米诺环素(MINO):1.56 - 12.5微克/毫升、0.78 - 3.13微克/毫升,卡那霉素(KM):3.13 - 6.25微克/毫升、25 - 100微克/毫升,磷霉素(FOM):3.13 - 25微克/毫升、0.78 - 6.25微克/毫升,诺氟沙星(NFLX):≤0.025 - 0.2微克/毫升、≤0.025 - 0.2微克/毫升,ABPC:1.56 -> 100微克/毫升、0.78 -> 100微克/毫升,头孢克洛(CCL):1.56 - 25微克/毫升、56 - 12.5微克/毫升。厌氧条件下CP和四环素类(TCs)的MIC低两倍,FOM的MIC低四倍,但NFLX、ABPC和CCL的MIC范围变化小。KM的MIC高。2. 我们观察到一些沙门氏菌属对CP、TCs和MINO高度耐药,一些对NFLX中度耐药。3. 空肠弯曲菌空肠亚种中TC耐药菌株以及NFLX不敏感或耐药菌株的检出频率高。4. 副溶血性弧菌和空肠弯曲菌空肠亚种菌株大多对ABPC和CCL耐药,其MIC处于高范围。5. 文献报道的MINO、KM、FOM和NFLX的粪便浓度足以具有一定抗菌活性,ABPC和CCL的给药剂量相当低。

相似文献

1
[The drug susceptibility pattern of the presumed etiologic agents of infectious enteritis including verotoxin-producing Escherichia coli O-157].[包括产志贺毒素大肠杆菌O-157在内的感染性肠炎假定病原体的药敏模式]
Jpn J Antibiot. 1997 Oct;50(10):829-43.
2
[Antibacterial activity of fosfomycin against the causative bacteria isolated from bacterial enteritis].
Jpn J Antibiot. 2000 Jul;53(7):522-31.
3
[Evaluation of antibiotics used for enterohemorrhagic Escherichia coli O157 enteritis--effect of various antibiotics on extracellular release of verotoxin].[用于肠出血性大肠杆菌O157肠炎的抗生素评估——各种抗生素对志贺毒素细胞外释放的影响]
Kansenshogaku Zasshi. 1997 Feb;71(2):130-5. doi: 10.11150/kansenshogakuzasshi1970.71.130.
4
[In vitro antibacterial activity of faropenem, a novel oral penem antibiotic, against enterohemorrhagic Escherichia coli O157 strains].新型口服青霉烯类抗生素法罗培南对肠出血性大肠杆菌O157菌株的体外抗菌活性
Jpn J Antibiot. 1999 Aug;52(8):541-53.
5
[In vitro antibacterial activity of fleroxacin (FLRX) against clinical isolates from bacterial enteritis].氟罗沙星(FLRX)对细菌性肠炎临床分离株的体外抗菌活性
Kansenshogaku Zasshi. 1994 Nov;68(11):1409-16. doi: 10.11150/kansenshogakuzasshi1970.68.1409.
6
[Activity of fosfomycin against Escherichia coli O157:H7--morphological changes and production of Shiga toxins].[磷霉素对大肠杆菌O157:H7的活性——形态学变化及志贺毒素的产生]
Jpn J Antibiot. 2003 Dec;56(6):691-6.
7
[Antibacterial activity of norfloxacin on methicillin-resistant Staphylococcus aureus. Comparison with oral antibacterial agents].
Jpn J Antibiot. 1990 Feb;43(2):228-32.
8
[Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1992). I. Susceptibility distribution].[1992年抗微生物剂对从尿路感染分离出的病原体的活性比较研究。I. 敏感性分布]
Jpn J Antibiot. 1995 Nov;48(11):1627-57.
9
[Evaluation of in vitro antibacterial potencies of oral antibiotics against sputum isolates].[口服抗生素对痰液分离株的体外抗菌效力评估]
Jpn J Antibiot. 1983 Aug;36(8):2103-8.
10
[Study on the drug sensitivity of multiple drug-resistant Staphylococcus aureus].[多重耐药金黄色葡萄球菌的药敏研究]
Jpn J Antibiot. 1985 Aug;38(8):2163-70.